
Jonathan Nahmany

TP ICAP Midcap keeps Maisons du Monde under review after its refinancing
The furniture and home decor chain is down 37% on the Paris stock market, with the share price off 85% since the start of the year. The group said on Friday that it had signed a conciliation agreement related to the group's refinancing. Two funds specializing in turnarounds of distressed companies, the Alteri Investors consortium and Eicos Investment Group, are providing 45.7m, including 33m of new cash for the company and 12.7m earmarked for the buyback of bank debt. TP ICAP Midcap is keeping the name under review.
June 22, 2026 at 06:01 am
Europe Lacks Clear Direction Ahead of PMI Data
European markets are trading without a clear direction this Monday, with investors still watching diplomatic developments in the Middle East. Shortly before 10:30 a.m., the CAC 40 was down 0.32% at 8,394 points. The Euro Stoxx 50 added 0.07% while London slipped 0.08%.
June 22, 2026 at 04:33 am

DMS strengthens its governance with Bpifrance joining the board
Diagnostic Medical Systems (DMS Group) said its shareholders unanimously approved the appointment of Bpifrance Investissement as a director at the annual general meeting held on June 15.
June 22, 2026 at 02:51 am
STMicroelectronics Expands Its Smart Sensor Lineup
The semiconductor maker announced the launch of the VL53L9, a new fully integrated 3D LiDAR module designed to set a new benchmark for high-resolution sensing in industrial and consumer applications.
June 22, 2026 at 02:39 am
ArcelorMittal steps up its digital transformation with AWS
The group announced a strategic partnership with Amazon Web Services (AWS) to speed up the automation of its industrial operations worldwide using cloud technologies, artificial intelligence, and edge computing solutions.
June 22, 2026 at 02:35 am
Transgene launches a clinical trial evaluating TG4070 with nivolumab
Transgene announced the start of a randomized Phase 1 trial evaluating TG4070, its personalized neoantigen-based therapeutic vaccine, in combination with nivolumab for the treatment of non-small cell lung cancer (NSCLC) after surgery.
June 22, 2026 at 02:27 am
Sanofi taps former Roche executive to lead Pharma R&D
The drugmaker announced the appointment of Dr. Paulo Fontoura as Executive Vice President, Global Head of Pharma Research & Development, effective September 1, 2026. Based in Paris and a member of the Executive Committee, he will report to CEO Belén Garijo.
June 22, 2026 at 02:22 am

Watera appoints Centre Capital Développement to its board of directors
Watera announced the appointment of Centre Capital Développement, represented by Bruno Jas, to its board of directors. The decision was approved at the companys annual general meeting, held on June 18
June 19, 2026 at 12:41 pm

Maisons du Monde Secures a Refinancing Agreement
The furniture and home decor retailer announced the signing of a conciliation protocol between a consortium of new investors made up of Alteri Investors and Eicos Investment Group and the group's banks. The agreement, reached under the supervision of the conciliators as part of the ongoing conciliation procedure, still needs to be approved by the specialized Commercial Court in Nantes and remains subject to several closing conditions.
June 19, 2026 at 06:25 am
Discover our authors
Journalist
Analyst
Analyst
Analyst
Journalist
- Stock Market
- Our authors
- Jonathan Nahmany






















